Finance

Lists
TCE2:FRA
Celldex Therapeutics Inc
€34.94
+3.83%
(+1.29) 1D
Aug 24, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for TCE2...
Open
€34.08
High
€34.94
Low
€34.08
Mkt. cap
3.19B
Avg. vol.
3.00
Volume
90.00
52-wk high
€38.34
52-wk low
€17.80
No. of employees
198
Open
€34.08
High
€34.94
Low
€34.08
Mkt. cap
3.19B
Avg. vol.
3.00
Volume
90.00
52-wk high
€38.34
52-wk low
€17.80
No. of employees
198
About Celldex Therapeutics Inc
CEO-
Employees198
Founded1983
HeadquartersHampton, New Jersey, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
121.00K
15.00K
22.00K
Cost of goods sold
62.93M
75.33M
73.00M
67.54M
Cost of revenue
62.93M
75.33M
73.00M
67.54M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.69M
11.94M
11.45M
13.10M
Operating expense
10.69M
11.94M
11.45M
13.10M
Total operating expenses
73.62M
87.27M
84.45M
80.64M
Operating income
-73.62M
-87.15M
-84.44M
-80.62M
Other non operating income
-
-
-
-
EBT including unusual items
-67.04M
-81.32M
-78.68M
-73.50M
EBT excluding unusual items
-67.04M
-81.32M
-78.68M
-73.50M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-67.04M
-81.32M
-78.68M
-73.50M
Net profit margin
-
-67,204.13%
-524,566.67%
-334,104.55%
Earnings per share
-1.01
-1.22
-1.18
-0.94
Interest and investment income
6.57M
5.84M
5.75M
7.12M
Interest expense
-
-
-
-
Net interest expenses
6.57M
5.84M
5.75M
7.12M
Depreciation and amortization charges
-
-
-
-
EBITDA
-72.79M
-86.34M
-83.58M
-79.72M
Gain or loss from assets sale
6.00K
-
3.00K
1.00K
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps